[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_7127 

# __Use of drugs in treatment of sars-cov-2 infection__

## Articles mentionning the risk

* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)

## Mitigations of this risk

* [Careful monitoring and evaluation of patient response](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_9008.md)

## Name of the risk

Potential adverse effects or drug interactions

## People affected by this risk

* [Patients receiving treatment for sars-cov-2 infection](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_6002.md)

## Stakeholders who can mitigate this risk

* [Healthcare providers and medical professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_6003.md)

## Technologies linked to the risk

* [Pharmacovigilance systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8680.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

